Drug
Fexuprazan
Fexuprazan is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)
NCT07497893
completedphase_3
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
NCT07326904
completed
Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
NCT05614752
Clinical Trials (3)
Showing 3 of 3 trials
NCT07497893Not Applicable
FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)
NCT07326904Phase 3
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
NCT05614752
Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3